Delivery Order SPE2DE24D0021-SPE2D625F9GM7
Award Date 7/29/25
Potential Completion Date 8/5/25
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 11, 2025, for the procurement of BINAXNOW COVID-19 Antigen Over-the-Counter test kits (12 tests per box, case quantity) with a ceiling value of $1,176.00. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of July 18, 2025. This award is a child contract under a larger vehicle and was issued without a set-aside designation, indicating open competition....
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Medical Supply Chain, a defense-affiliated federal agency, on June 2, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). The contract is structured as a fixed-price agreement with economic price adjustment provisions and is set to be completed by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Defense Medical Supply Chain on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment provisions represents a child contract under a larger vehicle and carries no set-aside designation. The order is scheduled for completion by August 26, 2025, with performance directed to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 by the Department of Defense's Medical Supply Chain on November 20, 2025, for BinaxNow COVID-19 antigen over-the-counter test kits (12 tests per case). This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract was competitively awarded with no set-aside designation and will be performed in Pittsburgh, Pennsylvania, where Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,087.00 on September 11, 2025, for the supply of BinaxNow COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment carries a completion deadline of September 18, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was issued by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $1,339.82 from the Department of Defense's Medical Supply Chain on December 4, 2025, for BINAXNOW COVID-19 Antigen OTC test kits (12 tests per box, case quantity). This fixed-price delivery order with economic price adjustment is expected to be completed by December 11, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition. This delivery...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,822.94 on April 24, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, which represents no set-aside designation, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of May 1, 2025. This delivery order is structured with economic price adjustment provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. Fisher...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,617.00 to Fisher Scientific Company L.L.C. on August 26, 2025, for the procurement of BinaxNOW COVID-19 antigen tests (12 tests per 2-test case). This fixed-price contract with economic price adjustment provisions is categorized as a child contract and does not utilize a set-aside designation, indicating open competition among qualified vendors. The place of performance is Pittsburgh, Pennsylvania, with...